Ingersoll Rand Inc. Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. Ingersoll Rand Inc. is a global provider of mission-critical flow creation products and industrial/life science solutions, operating through two reportable segments: Industrial Technologies and Services and Precision and Science Technologies. The company is a large accelerated filer with 403.5 million shares of common stock outstanding as of April 25, 2025.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenues | $1,716.8 million | $1,670.1 million |
| Net Income (Attributable to IR) | $186.5 million | $202.2 million |
| Diluted EPS | $0.46 | $0.50 |
| Operating Income | $302.5 million | $293.2 million |
| Adjusted EBITDA | $459.7 million | $458.5 million |
| Free Cash Flow | $222.7 million | $99.3 million |
| Total Debt | $4,772.1 million | $4,757.5 million |
| Cash and Equivalents | $1,612.8 million | $1,452.3 million |
| Operating Cash Flow | $256.4 million | $161.6 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 2.8% year-over-year, driven by acquisitions ($139.5 million) and higher pricing ($23.8 million), partially offset by lower organic volumes ($88.9 million) and unfavorable foreign currency impacts ($27.7 million).
- Profitability: Net income decreased 7.8% primarily due to higher interest expense ($61.2 million vs. $36.8 million) resulting from debt issued to fund the ILC Dover acquisition, and a higher effective tax rate (23.1% vs. 20.2%).
- Segment Performance:
- Industrial Technologies and Services: Revenues declined 1.6% and Adjusted EBITDA fell 5.4% due to lower organic volumes and unfavorable currency impacts.
- Precision and Science Technologies: Revenues surged 22.9% and Adjusted EBITDA rose 16.2%, largely driven by the ILC Dover acquisition and other recent acquisitions.
- Cash Flow: Operating cash flow improved significantly by $94.8 million, and Free Cash Flow more than doubled to $222.7 million due to lower capital expenditures ($33.7 million vs. $62.3 million) and improved working capital management.
Outlook, Risks, and Unusual Items
- Acquisitions: The company completed four acquisitions in Q1 2025 (SSI Aeration, Excelsior Blower, Cullum & Brown, and a sales/service business) for total consideration of approximately $166.7 million. These are expected to contribute to future growth in the Industrial Technologies segment.
- Share Repurchases: On May 1, 2025, the Board authorized an additional $1.0 billion increase to the share repurchase program, incremental to the $993.0 million remaining under the prior authorization.
- Interest Expense: Interest expense increased significantly due to the issuance of $3.3 billion in Senior Notes in May 2024 to fund the ILC Dover acquisition and refinance credit facilities.
- Risks: Management highlights risks related to global economic instability, inflation, geopolitical conflicts (Ukraine, Middle East), potential U.S. trade policy shifts and tariffs, and foreign currency fluctuations. The company notes that two reporting units in the Precision and Science Technologies segment have limited impairment cushions due to the recent ILC Dover acquisition.
Investor Verification Checklist
- Debt Servicing: Verify the sustainability of the increased interest expense ($61.2M in Q1) against future cash flow projections given the $4.77 billion debt load.
- Organic Volume Trends: Assess the cause and persistence of the $88.9 million decline in organic volumes, particularly in the Industrial Technologies segment.
- Acquisition Integration: Monitor the integration progress and synergy realization of the ILC Dover acquisition and Q1 2025 add-ons.
- Foreign Currency Exposure: Evaluate the impact of a strengthening U.S. dollar on future earnings, given that ~53% of revenue is non-USD denominated.
- Impairment Risk: Review the valuation of goodwill in the Precision and Science Technologies segment, specifically the reporting units with limited fair value cushions.